For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Kodiak Sciences Inc.

USPTO Granted Patents = 14

% Expired Patents = 7.1

EPO Patents = 9

Forward Citations = 65

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Daniel Victor Perlroth (10 out of 10 patents)

Wayne To (8 out of 18 patents)

Stephen A Charles (8 out of 22 patents)

4. Didier G Benoit (7 out of 16 patents)

5. Hong Liang (6 out of 11 patents)

6. James Bradley Aggen (5 out of 51 patents)

7. Martin Sheringham Linsell (5 out of 82 patents)

8. D Victor Perlroth (4 out of 7 patents)

9. Wah Yuen To (3 out of 3 patents)

10. Li Song (3 out of 6 patents)

11. Fernando Corrêa (3 out of 3 patents)

12. Lidia Mosyak (2 out of 16 patents)

13. Laura Lin (2 out of 11 patents)

14. Justin Cohen (2 out of 3 patents)

15. Tetsuya Ishino (2 out of 7 patents)

14 patents: Sort by Forward Citations

1. 12643958 - METHODS OF TREATING AN EYE DISORDER (2026-06-02),

2. 12466879 - COMPLEMENT FACTOR D ANTAGONIST ANTIBODIES AND CONJUGATES THEREOF (2025-11-11),

3. 12214044 - Factor VIII zwitterionic polymer conjugates (2025-02-04),

4. 12071476 - IL-6 antibodies and fusion constructs and conjugates thereof (2024-08-27),

5. 11912784 - Methods of treating an eye disorder (2024-02-27),

6. 11819531 - Multifunctional zwitterionic polymer conjugates (2023-11-21),

7. 11590235 - Factor VIII zwitterionic polymer conjugates (2023-02-28),

8. 11584790 - Complement factor D antagonist antibodies and conjugates thereof (2023-02-21),

9. 11155610 - Dual PDGF/VEGF antagonists (2021-10-26),

10. 11071771 - Butyrylcholinesterase zwitterionic polymer conjugates (2021-07-27),

11. 11066465 - Antibodies and conjugates thereof (2021-07-20),

12. 10702608 - Factor VIII zwitterionic polymer conjugates (2020-07-07),

13. 10363290 - Butyrylcholinesterase zwitterionic polymer conjugates (2019-07-30),

14. 9840553 - Dual PDGF/VEGF antagonists (2017-12-12),

Kodiak Sciences is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of novel therapies to treat retinal diseases. Their lead product candidate, KSI-301, is being evaluated in ongoing clinical trials for the treatment of age-related macular degeneration, diabetic macular edema, and retinal vein occlusion.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

14 Patents

#126 in Palo Alto, CA

#5,305 in California

#22,262 in US

#42,118 in the World

Palo Alto, CA, United States of America

Kodiak Sciences Inc.

Forward Citations = 65

25 inventors:

Daniel Victor Perlroth (10 out of 10 patents)

Wayne To (8 out of 18 patents)

Stephen A Charles (8 out of 22 patents)

4. Didier G Benoit (7 out of 16 patents)

5. Hong Liang (6 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…